Post Hepatitis C Cirrhosis in Sub-Sahara Kidney Transplant, Treated with Sofosbuvir/Ledipasvir: Report of Case and Review of Literature
- 1 Nephrology and Dialysis Department of Teaching Hospital Sylvanus Olympio, University of Lomé, Lomé, Togo
- 2 Néphrology, Hémodialysis and Organ Transplant Departement of Yopougon Teaching Hospital, University Felix Houphouet Boigny, Abidjan, Cote d’Ivoire
- 3 Néphrology, Hémodialysis and Organ Transplant Departement of Yopougon Teaching Hospital, University Felix Houphouet Boigny, Abidjan, Cote d’Ivoire
- 4 Néphrology, Hémodialysis and Organ Transplant Departement of Yopougon Teaching Hospital, University Felix Houphouet Boigny, Abidjan, Cote d’Ivoire
- 5 Néphrology, Hémodialysis and Organ Transplant Departement of Yopougon Teaching Hospital, University Felix Houphouet Boigny, Abidjan, Cote d’Ivoire
- 6 Néphrology, Hémodialysis and Organ Transplant Departement of Yopougon Teaching Hospital, University Felix Houphouet Boigny, Abidjan, Cote d’Ivoire
- 7 Néphrology, Hémodialysis and Organ Transplant Departement of Yopougon Teaching Hospital, University Felix Houphouet Boigny, Abidjan, Cote d’Ivoire
Abstract
Background: Viral hepatitis C is a major public health problem in the world. The advent of direct-acting antivirals has revolutionized the taking in charge and prognosis of patients infected with the hepatitis C virus. The interest of this presentation is to draw attention to the problem of therapeutic care posed by viral hepatitis C in kidney transplant patients in C?te d’Ivoire, a country with limited resources where all direct-acting antivirals are not yet available. Patient observation: We report the case of a kidney transplant of 52 years old, chronic bearer of viral hepatitis C virus who after his kidney transplant presented, decompensated active cirrhosis. A treatment based on Sofosbuvir 400 mg/Ledipasvir 90 mg in this patient with genotype 2 for 12 weeks was initiated. A sustained virological response was observed 12 weeks after the end of treatment. Conclusion: Direct-acting antivirals offer the possibility of antiviral C treatment without interferon or ribavirin in cirrhotic renal transplant.
- Scott, D.R., Wong, J.K., Spicer, T.S., Dent, H., Mensah, F.K., et al. (2010) Adverse Impact of Hepatitis C Virus Infection on Renal Replacement Therapy and Renal Transplant Patients in Australia and New Zealand. Transplantation, 90, 1165-1171. https://doi.org/10.1097/TP.0b013e3181f92548
- Baid-Agrawal, S., et al. (2014) Hepatitis C Virus Infection and Kidney Transplantation in 2014: What’s New? American Journal of Transplantation, 14, 2206-2220. https://doi.org/10.1111/ajt.12835
- Morales, J.M. and Campistol, J.M. (2000) Transplantation in the Patient with Hepatitis C. Journal of the American Society of Nephrology, 11, 1343-1353.
- Rostaing, L., Izopet, J., Sandres, K., Cisterne, J.M., Puel, J. and Durand, D. (2000) Changes in Hepatitis C Virus RNA Viremia Concentrations in Long-Term Renal Transplant Patients after Introduction of Mycophenolate Mofetil. Transplantation, 69, 991-994. https://doi.org/10.1097/00007890-200003150-00055
- Magrin, S., Craxi, A., Fabiano, C., et al. (1994) Hepatitis C Viremia in Chronic Liver Disease: Relationship to Interferon-Alfa or Corticosteroid Treatment. Hepatology, 19, 273-279. https://doi.org/10.1002/hep.1840190203
- Izopet, J., Rostaing, L., Sandres, K., et al. (2000) Longitudinal Analysis of Hepatitis C Virus Replication and Liver Fibrosis Progression in Renal Transplant Recipients. The Journal of Infectious Diseases, 181, 852-858. https://doi.org/10.1086/315355
- Kamar, N., Rostaing, L., Boulestin, A., et al. (2003) Evolution of Hepatitis C Virus Quasispecies in Renal Tranplant Patients with De Novo Glomerolonephritis. Journal of Medical Virology, 69, 482-488. https://doi.org/10.1002/jmv.10335
- Alric, L. Di-Martino, V., Selves, J., Cacoub, P., et al. (2002) Long-Term Impact of Renal Transplantation on Liver Fibrosis during Hepatitis C Virus Infection. Gastroenterology, 123, 1494-1499. https://doi.org/10.1053/gast.2002.36610
- Hestin, D., Guillemin, F., Castin, N., Le Faou, A., Champigneulles, J. and Kessler, M. (1998) Pretransplant Hepatitis C Virus Infection: A Predicator of Proteinuria after Renal Transplantation. Transplantation, 65, 741-744. https://doi.org/10.1097/00007890-199803150-00024
- Cosio, F.G., Sedmak, D.D., Henry, M.L., et al. (1996) The High Prevalence of Severe Early Post-Transplant Renal Allograft Pathology in Hepatitis C Positive Recipients. Transplantation, 62, 1054-1059. https://doi.org/10.1097/00007890-199610270-00004
- Pascual, J., Crespo, M., Mateos, M.L., et al. (1998) Reduced Severity of Acute Rejection in Hepatitis C Virus Positive Renal Allograft Recipients: Are Milder Immunosuppressive Regimens Advisable? Transplantation Proceedings, 30, 1329-1330. https://doi.org/10.1016/S0041-1345(98)00263-2